These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25004789)

  • 41. Clinical Question: In congestive heart failure patients with preserved ejection fraction, does spironolactone improve cardiac outcomes?
    Onarecker C
    J Okla State Med Assoc; 2016 Sep; 109(9):437-8. PubMed ID: 29261854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal Strain in Heart Failure With Preserved Ejection Fraction: Is There a Role for Prognostication?
    Mentz RJ; Khouri MG
    Circulation; 2015 Aug; 132(5):368-70. PubMed ID: 26130120
    [No Abstract]   [Full Text] [Related]  

  • 43. A review regarding the article 'Mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: a network meta-analysis of 32 randomized trials'.
    Wang L; Yuan D
    Curr Probl Cardiol; 2024 Aug; 49(8):102644. PubMed ID: 38750993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT.
    Grodin JL; Philips S; Mullens W; Nijst P; Martens P; Fang JC; Drazner MH; Tang WHW; Pandey A
    Eur J Heart Fail; 2019 May; 21(5):634-642. PubMed ID: 30714658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. QRS Duration Is a Predictor of Adverse Outcomes in Heart Failure With Preserved Ejection Fraction.
    Joseph J; Claggett BC; Anand IS; Fleg JL; Huynh T; Desai AS; Solomon SD; O'Meara E; Mckinlay S; Pitt B; Pfeffer MA; Lewis EF
    JACC Heart Fail; 2016 Jun; 4(6):477-86. PubMed ID: 27039126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study.
    Vazir A; Claggett B; Pitt B; Anand I; Sweitzer N; Fang J; Fleg J; Rouleau J; Shah S; Pfeffer MA; Solomon SD
    JACC Heart Fail; 2017 Nov; 5(11):782-791. PubMed ID: 29032132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Spironolactone on Exercise Tolerance and Arterial Function in Older Adults with Heart Failure with Preserved Ejection Fraction.
    Upadhya B; Hundley WG; Brubaker PH; Morgan TM; Stewart KP; Kitzman DW
    J Am Geriatr Soc; 2017 Nov; 65(11):2374-2382. PubMed ID: 28542926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk Stratification and Efficacy of Spironolactone in Patients with Heart Failure with Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial.
    Lin Y; Zhong X; Liu M; Zhang S; Xiong Z; Huang Y; Fan Y; Xu X; Guo Y; Li Y; Sun X; Zhou H; Yang D; Ye X; Liao X; Zhuang X
    Cardiovasc Drugs Ther; 2022 Apr; 36(2):323-331. PubMed ID: 33791916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spironolactone Reduces the Risk of Death in Veterans With Heart Failure With Preserved Ejection Fraction.
    Kurgansky KE; Parker R; Djousse L; Gagnon DR; Joseph J
    J Am Heart Assoc; 2024 Jul; 13(14):e032231. PubMed ID: 38979805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Should MRAs be at the front row in heart failure? A plea for the early use of mineralocorticoid receptor antagonists in medical therapy for heart failure based on clinical experience.
    Heggermont WA; Goethals M; Dierckx R; Verstreken S; Bartunek J; Vanderheyden M
    Heart Fail Rev; 2016 Nov; 21(6):699-701. PubMed ID: 27620301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Weight changes in heart failure with preserved ejection fraction: findings from TOPCAT.
    Ferreira JP; Rossignol P; Claggett BL; Solomon SD; Pitt B; Pfeffer M; Zannad F
    Clin Res Cardiol; 2022 Apr; 111(4):451-459. PubMed ID: 34757487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aldosterone Receptor Blockade in Heart Failure with Preserved Ejection Fraction.
    Nair A; Deswal A
    Heart Fail Clin; 2018 Oct; 14(4):525-535. PubMed ID: 30266361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction.
    Biering-Sørensen T; Shah SJ; Anand I; Sweitzer N; Claggett B; Liu L; Pitt B; Pfeffer MA; Solomon SD; Shah AM
    Eur J Heart Fail; 2017 Aug; 19(8):1043-1052. PubMed ID: 28322009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between long-term prescription of aldosterone antagonist and the progression of heart failure with preserved ejection fraction in hypertensive patients.
    Gu J; Fan YQ; Han ZH; Fan L; Bian L; Zhang HL; Xu ZJ; Yin ZF; Xie YS; Zhang JF; Wang CQ
    Int J Cardiol; 2016 Oct; 220():56-60. PubMed ID: 27372043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A composite metric for predicting benefit from spironolactone in heart failure with preserved ejection fraction.
    Belkin MN; Blair JE; Shah SJ; Alenghat FJ
    ESC Heart Fail; 2021 Oct; 8(5):3495-3503. PubMed ID: 34369088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Previous heart failure hospitalization, spironolactone, and outcomes in heart failure with preserved ejection fraction - a secondary analysis of TOPCAT.
    Szabo B; Benson L; Savarese G; Hage C; Fudim M; Devore A; Pitt B; Lund LH
    Am Heart J; 2024 May; 271():136-147. PubMed ID: 38412897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical information from repeated blood pressure measurements in the management of heart failure with preserved ejection fraction.
    Wei FF; Zhou Y; Wu Y; Chen X; He J; Dong Y; Staessen JA; Liu C
    Hypertens Res; 2023 Feb; 46(2):475-484. PubMed ID: 36380201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.